Alexandra holds a BSc in psychology with continued studies in neuroscience and pharmacology. She also holds an interdisciplinary Med. Licentiate, merging the fields of neuropharmacology, psychiatry and immunology from the Karolinska Institute, Stockholm, Sweden. Her previous research focused on interaction between the immune- and neurotransmitter systems regarding psychotic disorders.
A revolutionary gene-editing method can create high-power immune cells that kill tumor cells for a longer time before they become “exhausted,” a study with a leukemia mouse model indicates. Using the CRISPR/Cas9 ... Read more
Immune analysis of tumor biopsies during the course of early treatment can predict patients’ response to melanoma immunotherapy, according to the conclusions of a study that included 53 melanoma patients treated with ... Read more